Fukuda Misao, Mukohara Toru, Kuwata Takeshi, Sunami Kuniko, Naito Yoichi
Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Department of Genetic Medicine and Services, National Cancer Center Hospital East, Kashiwa, Japan.
JCO Precis Oncol. 2024 Aug;8:e2300649. doi: 10.1200/PO.23.00649.
Trametinib, an MEK inhibitor, may offer a new therapeutic option for patients with NF1-related GIST.
曲美替尼,一种MEK抑制剂,可能为患有1型神经纤维瘤病相关胃肠道间质瘤的患者提供一种新的治疗选择。